153 related articles for article (PubMed ID: 9840302)
21. The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma.
von Mehren M; Arlen P; Gulley J; Rogatko A; Cooper HS; Meropol NJ; Alpaugh RK; Davey M; McLaughlin S; Beard MT; Tsang KY; Schlom J; Weiner LM
Clin Cancer Res; 2001 May; 7(5):1181-91. PubMed ID: 11350882
[TBL] [Abstract][Full Text] [Related]
22. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
23. Recombinant human granulocyte-macrophage colony-stimulating factor hydrogel promotes healing of deep partial thickness burn wounds.
Yan H; Chen J; Peng X
Burns; 2012 Sep; 38(6):877-81. PubMed ID: 22652468
[TBL] [Abstract][Full Text] [Related]
24. Granulocyte-macrophage colony-stimulating factor enhances wound healing in diabetes via upregulation of proinflammatory cytokines.
Fang Y; Shen J; Yao M; Beagley KW; Hambly BD; Bao S
Br J Dermatol; 2010 Mar; 162(3):478-86. PubMed ID: 19799605
[TBL] [Abstract][Full Text] [Related]
25. Recombinant bovine basic fibroblast growth factor accelerates wound healing in patients with burns, donor sites and chronic dermal ulcers.
Fu X; Shen Z; Chen Y; Xie J; Guo Z; Zhang M; Sheng Z
Chin Med J (Engl); 2000 Apr; 113(4):367-71. PubMed ID: 11775238
[TBL] [Abstract][Full Text] [Related]
26. Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.
de Gast GC; Klümpen HJ; Vyth-Dreese FA; Kersten MJ; Verra NC; Sein J; Batchelor D; Nooijen WJ; Schornagel JH
Clin Cancer Res; 2000 Apr; 6(4):1267-72. PubMed ID: 10778950
[TBL] [Abstract][Full Text] [Related]
27. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
Evans TG; Schiff M; Graves B; Agosti J; Barritt ML; Garner D; Holley JL
Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
[TBL] [Abstract][Full Text] [Related]
28. Impaired cutaneous wound healing in granulocyte/macrophage colony-stimulating factor knockout mice.
Fang Y; Gong SJ; Xu YH; Hambly BD; Bao S
Br J Dermatol; 2007 Sep; 157(3):458-65. PubMed ID: 17553038
[TBL] [Abstract][Full Text] [Related]
29. New clinical applications of granulocyte-macrophage colony-stimulating factor.
Masucci G
Med Oncol; 1996 Sep; 13(3):149-54. PubMed ID: 9106173
[TBL] [Abstract][Full Text] [Related]
30. Phase 2 study of granulocyte-macrophage colony-stimulating factor plus thalidomide in patients with hormone-naïve adenocarcinoma of the prostate.
Amato RJ; Hernandez-McClain J; Henary H
Urol Oncol; 2009; 27(1):8-13. PubMed ID: 18367123
[TBL] [Abstract][Full Text] [Related]
31. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
[TBL] [Abstract][Full Text] [Related]
32. Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: a potential role for growth factor as mucosal protectant.
Meropol NJ; Rustum YM; Creaven PJ; Blumenson LE; Frank C
Cancer Invest; 1999; 17(1):1-9. PubMed ID: 10999043
[TBL] [Abstract][Full Text] [Related]
33. The effect of GM-CSF (granulocyte macrophage colony stimulating factor) on doxorubicin induced tissue necrosis and wound healing.
Eroglu E; Sari A; Altuntas I; Delibas N; Candir C; Agalar F
Indian J Cancer; 2000 Dec; 37(4):153-7. PubMed ID: 12018567
[TBL] [Abstract][Full Text] [Related]
34. Influence of growth factors erythropoietin and granulocyte macrophage colony stimulating factor on mechanical strength and healing of colonic anastomoses in rats.
Fatouros MS; Vekinis G; Bourantas KL; Mylonakis EP; Scopelitou AS; Malamou-Mitsis VD; Kappas AM
Eur J Surg; 1999 Oct; 165(10):986-92. PubMed ID: 10574109
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant.
Yağci M; Acar K; Sucak GT; Yamaç K; Haznedar R
Eur J Haematol; 2007 Oct; 79(4):292-6. PubMed ID: 17655695
[TBL] [Abstract][Full Text] [Related]
36. Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infection.
Jacobson JM; Lederman MM; Spritzler J; Valdez H; Tebas P; Skowron G; Wang R; Jackson JB; Fox L; Landay A; Gilbert MJ; O'Neil D; Bancroft L; Al-Harthi L; Jacobson MA; Merigan TC; Glesby MJ;
J Infect Dis; 2003 Dec; 188(12):1804-14. PubMed ID: 14673758
[TBL] [Abstract][Full Text] [Related]
37. Effects of granulocyte macrophage colony stimulating factor on random flap healing and immune profile in rats with impaired wound healing by glucocorticoids.
Ergün SS; Kýran B; Su O; Bilgiç B; Yssever H; Küçük M
Ann Plast Surg; 2004 Jan; 52(1):80-8. PubMed ID: 14676705
[TBL] [Abstract][Full Text] [Related]
38. Sequential administration of interferon-gamma, GM-CSF, and interleukin-2 in patients with metastatic renal cell carcinoma: results of a phase II trial.
Schmidinger M; Steger G; Wenzel C; Locker GJ; Budinsky AC; Brodowicz T; Kramer G; Marberger M; Zielinski CC;
J Immunother; 2001; 24(3):257-62. PubMed ID: 11394504
[TBL] [Abstract][Full Text] [Related]
39. IL-10 and GM-CSF expression and the presence of antigen-presenting cells in chronic venous ulcers.
Li YQ; Doyle JW; Roth TP; Dunn RM; Lawrence WT
J Surg Res; 1998 Oct; 79(2):128-35. PubMed ID: 9758727
[TBL] [Abstract][Full Text] [Related]
40. [rHuGM-CSF: a possible therapeutic treatment in resistant chronic wound healing: our first observations].
Castrogiovanni P; Ventimiglia P; Imbesi R
Clin Ter; 2010; 161(3):e101-4. PubMed ID: 20589341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
